Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular paracetamol + hyoscine butylbromide versus intramuscular pentazocine for labour pain
PACTR202506913477224Phase 3Recruiting
- Sponsor
- Eze Jeremiah
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Intramuscular paracetamol + hyoscine butylbromide with Intramuscular pentazocine (2 arms). Primary endpoints: Mean pain score and Safety. Started Dec 2024; status: recruiting.
02
Drugs
acetaminophenhyoscine butylbromidepentazocine
Beyond the preview
Go deeper on PACTR202506913477224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506913477224.